A PDGFRβ-PI3K signaling axis mediates periosteal cell activation during fracture healing

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Skeletal Biology

Background:

• Delayed fracture healing is a significant clinical challenge with limited treatments.
• Phosphoinositide 3-kinase (PI3K) signaling is vital for osteoprogenitor cells, influencing proliferation, migration, and differentiation.
• Global increase in PI3K signaling in gCblYF mice enhances femoral fracture healing, particularly the periosteal response.

Purpose of the Study:

• To investigate the hypothesis that Platelet-Derived Growth Factor Receptor beta (PDGFRβ) and PI3K interaction is essential for periosteal cell activation post-fracture.
• To analyze the crosstalk between PDGFRβ and PI3K signaling pathways in primary periosteal cells from gCblYF mice.

Main Methods:

• Isolation and analysis of primary periosteal cells from gCblYF mice.
• Assessment of signaling pathway crosstalk, focusing on PDGFRβ and PI3K.
• Generation of gCblYF mice with conditional PDGFRβ depletion in mesenchymal progenitors using αSMA CreERT2.
• Induction of femoral fractures and analysis of periosteal activation and proliferation at three days post-fracture.

Main Results:

• PDGFRβ signaling significantly enhances Akt phosphorylation in periosteal cells compared to other growth factors.
• Conditional depletion of PDGFRβ in mesenchymal progenitors abrogates PI3K-mediated periosteal activation and proliferation early in fracture healing.
• gCblYF mice exhibit enhanced fracture healing with a pronounced periosteal response.

Conclusions:

• PDGFRβ signaling, acting through PI3K, is indispensable for robust periosteal activation during the initial stages of fracture healing.
• Targeting the PDGFRβ-PI3K axis may offer a therapeutic strategy for improving fracture healing outcomes.
• Understanding this signaling crosstalk provides insights into mechanisms regulating bone repair.